Requires drug middlemen to pass on rebates and extends telehealth access for millions.
This bill would extend funding for many important health programs, from community health centers to opioid treatment. It would also make big changes to how prescription drug costs are handled by requiring pharmacy benefit managers to pass on rebates to health plans. Additionally, it would extend Medicare telehealth services and make other updates to Medicaid and Medicare.
Today, pharmacy benefit managers often keep a portion of the rebates and discounts they negotiate from drug manufacturers. This can make prescription drugs more expensive for health plans and consumers. Many federal health programs and telehealth flexibilities are also set to expire soon. If this bill becomes law, PBMs would be required to pass all rebates and discounts directly to health plans, potentially lowering drug costs. It would also extend crucial funding for a wide range of health services and continue Medicare's expanded telehealth options for several more years.
S 891 · 119th Congress · March 6, 2025 · AI Summary by gemini-2.5-flash · 4/10
Sign in to see your representatives' phone numbers
84 filings mentioned this bill
Amounts reflect total quarterly lobbying spend reported to the Senate, not bill-specific spending. Source: Senate LDA filings.